Corrigendum to "comparison of outcomes for MR-guided versus CT-guided high-dose-rate interstitial brachytherapy in women with locally advanced carcinoma of the cervix" [Gynecol. Oncol. 145 (2017) 284-290]
Gynecol Oncol. 2017 Aug;146(2):440.
doi: 10.1016/j.ygyno.2017.05.035.
Epub 2017 May 31.
1 Harvard Radiation Oncology Program, Boston, MA, United States. Electronic address: Sophia_kamran@post.harvard.edu.
2 Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, United States; Bronx-Lebanon Hospital Center, Bronx, NY, United States.
3 Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, United States; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
4 Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, United States; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
5 Department of Radiology, Brigham and Women's Hospital, Boston, Boston, MA, United States.
6 Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
7 Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA, United States; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, United States; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, United States.